National Health (Listing of Pharmaceutical Benefits) Instrument 2024
22Listed drugs and pharmaceutical benefits that can only be supplied under the prescriber bag provisions (Act s 85(2AA) and (7A))
Start here
Get a plain-English read of 22
Turn the raw legal text into a practical explanation grounded in National Health (Listing of Pharmaceutical Benefits) Instrument 2024.
22 Listed drugs and pharmaceutical benefits that can only be supplied under the prescriber bag provisions (Act s 85(2AA) and (7A))
Listed drugs (1) For the purposes of subsection 85(2AA) of the Act, if one or more of the codes “D(MP)”, “D(MW)” and “D(NP)” are mentioned in the column of a table in Schedule 1 to this instrument headed “Section 100/Prescriber Bag only” in relation to a listed drug, then the listed drug can only be supplied under: (a) if the code D(MP) is mentioned—section 93 of the Act (prescriber bag supplies—medical practitioners); and (b) if the code D(MW) is mentioned—section 93AA of the Act (prescriber bag supplies—authorised midwives); and (c) if the code D(NP) is mentioned—section 93AB of the Act (prescriber bag supplies—authorised nurse practitioners). Pharmaceutical benefits (2) For the purposes of subsection 85(7A) of the Act, if one or more of the codes “PB(MP)”, “PB(MW)” and “PB(NP)” are mentioned in the column of a table in Schedule 1 to this instrument headed “Section 100/Prescriber Bag only” in relation to a pharmaceutical benefit, then the pharmaceutical benefit can only be supplied in accordance with the following: (a) if the code PB(MP) is mentioned—section 93 of the Act (prescriber bag supplies—medical practitioners); (b) if the code PB(MW) is mentioned—section 93AA of the Act (prescriber bag supplies—authorised midwives); (c) if the code PB(NP) is mentioned—section 93AB of the Act (prescriber bag supplies—authorised nurse practitioners).
Note: For the interaction between a declaration under subsection 85(2AA) of the Act in relation to a drug and a declaration under subsection 85(7A) of the Act in relation to a pharmaceutical benefit that has the drug, see subsection 85AAA(3) of the Act.